1.41
price down icon2.08%   -0.03
pre-market  Pre-market:  1.43   0.02   +1.42%
loading
Pmv Pharmaceuticals Inc stock is traded at $1.41, with a volume of 285.87K. It is down -2.08% in the last 24 hours and up +29.36% over the past month. PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
See More
Previous Close:
$1.44
Open:
$1.44
24h Volume:
285.87K
Relative Volume:
1.06
Market Cap:
$73.25M
Revenue:
-
Net Income/Loss:
$-51.47M
P/E Ratio:
-1.41
EPS:
-1
Net Cash Flow:
$-47.50M
1W Performance:
+6.02%
1M Performance:
+29.36%
6M Performance:
+2.92%
1Y Performance:
-14.55%
1-Day Range:
Value
$1.37
$1.4667
1-Week Range:
Value
$1.27
$1.50
52-Week Range:
Value
$0.81
$1.82

Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile

Name
Name
Pmv Pharmaceuticals Inc
Name
Phone
(609) 642-6670
Name
Address
400 ALEXANDER PARK DRIVE, PRINCETON
Name
Employee
47
Name
Twitter
Name
Next Earnings Date
2025-03-04
Name
Latest SEC Filings
Name
PMVP's Discussions on Twitter

Compare PMVP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
PMVP
Pmv Pharmaceuticals Inc
1.41 74.81M 0 -51.47M -47.50M -1.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-08-24 Upgrade Oppenheimer Perform → Outperform
May-13-24 Initiated Craig Hallum Buy
Apr-12-24 Initiated Jefferies Buy
Dec-27-23 Initiated Ladenburg Thalmann Buy
Mar-02-22 Upgrade Oppenheimer Perform → Outperform
Sep-22-21 Upgrade Goldman Neutral → Buy
Aug-19-21 Initiated Oppenheimer Perform
Aug-02-21 Initiated Guggenheim Buy
Jul-29-21 Initiated H.C. Wainwright Buy
Oct-20-20 Initiated BofA Securities Buy
Oct-20-20 Initiated Cowen Outperform
Oct-20-20 Initiated Evercore ISI Outperform
Oct-20-20 Initiated Goldman Neutral
View All

Pmv Pharmaceuticals Inc Stock (PMVP) Latest News

pulisher
07:02 AM

Visual analytics tools that track PMV Pharmaceuticals Inc. performanceEquity Signal Recap With Long-Term Summary - Newser

07:02 AM
pulisher
05:27 AM

Using data models to predict Angi Inc. stock movementValue Investing Checklist with Entry Signals - Newser

05:27 AM
pulisher
05:26 AM

How to integrate PMV Pharmaceuticals Inc. into portfolio analysis toolsFree Watchlist for Low Risk High Return - Newser

05:26 AM
pulisher
Jul 27, 2025

Should I hold or sell PMV Pharmaceuticals Inc. stock in 2025Consistently outstanding ROI - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are PMV Pharmaceuticals Inc. company’s key revenue driversUncover the best stocks for explosive growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What analysts say about PMV Pharmaceuticals Inc. stock outlookAI Powered Stock Call - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

What are FURY company’s key revenue driversStrong return on assets - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Smith Midland Corporation Stock Support and Resistance Levels You Should KnowInvestor Favorite Picks - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Buy Signal for The Hanover Insurance Group Inc. Stock Key Technical Indicators to WatchConsistent Growth Alert - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

When is PMV Pharmaceuticals Inc. stock expected to show significant growthConsistently profitable trades - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How Efficient Is MATW at Controlling Operating CostsProven Win Setups - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Why PMV Pharmaceuticals Inc. stock attracts strong analyst attentionCapital Safe Smart Trades - Newser

Jul 27, 2025
pulisher
Jul 26, 2025

How Tennant Company stock performs during market volatilityFree Market Dynamics Reports - Newser

Jul 26, 2025
pulisher
Jul 25, 2025

What analysts say about PMV Pharmaceuticals Inc. stockSkyrocketing returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Macro Trends and Their Impact on IVP Limited (507580)Exceptional market positioning - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Best Electric Vehicle Stocks in India Premium Investment RecommendationsOutperformance with explosive growth - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Will RMCF stock benefit from AI tech trendsRapid capital growth - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Is PMV Pharmaceuticals Inc. stock overhyped or has real potentialStrong return on assets - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

What drives PMV Pharmaceuticals Inc. stock priceSuperior risk-adjusted returns - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Is PMV Pharmaceuticals Inc. a good long term investmentOutstanding investment returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about IRIDEX Corporation stockFree Expert Stock Watchlist - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

PMV Pharmaceuticals Inc. Stock Analysis and ForecastExceptional market performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about SAGE stockRemarkably fast returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

NECB Stock Analysis and ForecastRobust investment performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

CHSN Stock Analysis and ForecastFree Trading Psychology Coaching - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What drives TopBuild Corp. stock priceGame-changing capital returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Principal Financial Group Inc. stockExponential wealth increase - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Advantage Solutions Inc. stockMassive wealth growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How PMV Pharmaceuticals Inc. stock performs during market volatilityMassive Upside Selection - Newser

Jul 22, 2025
pulisher
Jul 20, 2025

Exploring India’s Stock Market through ETFs and Mutual Funds Consistent Stock Market ReturnsUnmatched profit potential - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

What drives Assurant Inc. stock priceMarket-beating performance - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

Benares Hotels Limited (509438) to Launch New Product LineSuperior returns - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

Is Red River Bancshares Inc. a good long term investmentDynamic investment growth - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

Best Stocks for Long Term Capital Appreciation in India Expert Selected High Growth StocksFree Consultation - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

What drives ATLCP stock priceTremendous wealth creation - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Top Green Stocks to Buy Expert Verified Trading AlertsAccelerated profit realization - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

P 500 Structured Alt Protection Etf February stock priceTriple-digit profit margins - jammulinksnews.com

Jul 19, 2025

Pmv Pharmaceuticals Inc Stock (PMVP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Pmv Pharmaceuticals Inc Stock (PMVP) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Jalota Deepika
Chief Development Officer
Jul 01 '25
Sale
1.06
33,065
35,198
89,959
Carulli Michael
Chief Financial Officer
Jul 01 '25
Sale
1.06
28,249
30,077
60,146
Mack David Henry
President and CEO
Jul 01 '25
Sale
1.06
58,411
62,179
536,133
Mack David Henry
President and CEO
Dec 03 '24
Option Exercise
0.53
91,750
48,628
534,210
Mack David Henry
President and CEO
Jan 03 '25
Option Exercise
0.53
17,709
9,386
551,919
Jalota Deepika
Chief Development Officer
Sep 11 '24
Sale
1.50
7,218
10,853
118,283
Carulli Michael
Chief Financial Officer
Sep 11 '24
Sale
1.50
2,891
4,347
88,395
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Cap:     |  Volume (24h):